Overview

Open-Label Duloxetine Extension Phase in Patients Who Have Completed Previous Duloxetine Trials

Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
A study in patients with depression
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Duloxetine Hydrochloride